Thought Leadership for Life Science Leaders

Blog

Speak to Our Thought Leaders Today

Beyond the Signature: Reexamining Informed Consent in Clinical Research

Beyond the Signature: Reexamining Informed Consent in Clinical Research

Informed consent in clinical research is often considered a regulatory checkbox, but it deserves far more attention. At its core, it’s an ongoing ethical commitment to transparency, respect, and protecting human participants. Yet too often, informed consent is reduced to paperwork. At Compliance Architects, we believe this critical process must evolve to meet the demands […]

100 Years of Consent: The History of Informed Consent & Why the Past Still Shapes Today’s Research Ethics

Informed consent is not a checkbox. It’s not merely a form signed and filed. It is a living, ethical, and regulatory process rooted in the foundational values of autonomy, transparency, and respect for individuals. As clinical research grows more complex and diverse, with digital platforms, decentralized trials, and global recruitment, the principles of informed consent […]

Understanding the Impact of ICH E6 on Your GCP Quality and Compliance Program

Understanding the Impact of ICH E6 on Your GCP Quality and Compliance Program

Quality Assurance (QA) in Clinical Development has significantly changed over the past two decades. The US Code of Federal Regulations (CFR) initially did not explicitly mandate a system for managing quality throughout all stages of the clinical trial process. However, developing the FDA’s Bioresearch Monitoring (BIMO) Program and subsequent international standards has transformed the landscape […]

ICH E6(R3): Ushering in a New Era of Clinical Trial Oversight

ICH E6(R3): Ushering in a New Era of Clinical Trial Oversight

In May 2023, the International Council for Harmonization (ICH) released the Step 2 draft of ICH E6(R3) for public consultation. This transformative update marks a significant milestone in the evolution of Good Clinical Practice (GCP). On May 22, 2024, the ICH announced the final Step 5 version of ICH E6(R3), a transformational update to the […]

How a Strong Quality Culture Drives Successful Acquisitions in MedTech

MedTech: A Growing Industry for Mergers and Acquisitions The MedTech industry creates life-changing products to improve patient care. Companies in this field often merge, buy, or sell to grow their businesses. But these deals do not always succeed. Problems can arise when companies do not plan well or fail to focus on quality. A strong […]

NAVIGATING YOUR QUALITY JOURNEY

Navigating Your Quality Journey: Crafting a 3-Year Road Map

In today’s rapidly evolving regulatory landscape, ensuring a robust quality culture is essential for any organization in the biopharmaceutical industry. Our latest infographic below offers a clear visual guide on how Compliance Architects can help you map out your quality strategy over the next three years. See the infographic below. The Journey Begins: Check Your […]